Summit Trail Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
10,765
+5,113
+90% +$852K 0.02% 730
2026
Q1
$1.19M Buy
5,652
+60
+1% +$15.1K 0.02% 860
2025
Q4
$1.59M Sell
5,592
-690
-11% -$216K 0.03% 548
2025
Q3
$1.94M Buy
6,282
+3,166
+102% +$992K 0.03% 462
2025
Q2
$979K Buy
3,116
+1,314
+73% +$379K 0.02% 491
2025
Q1
$473K Sell
1,802
-80
-4% -$21.7K 0.02% 262
2024
Q4
$491K Buy
+1,882
New +$474K 0.02% 220

Other funds holding PODD

Summit Trail Advisors's PODD Position: Q2 2026 in Review

Summit Trail Advisors increased its Insulet (PODD) stake by 90% in Q2 2026, buying an estimated $852K and bringing the position to 10,765 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #730.

Summit Trail Advisors first reported a position in PODD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.94M in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Summit Trail Advisors held 10,765 shares of Insulet worth $1.64M as of Q2 2026.
  • Summit Trail Advisors bought 5,113 Insulet shares in Q2 2026, an estimated $852K.
  • Insulet made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #730 holding.
  • Summit Trail Advisors first reported a position in Insulet in Q4 2024 and has held it in 7 quarters since.
  • Summit Trail Advisors's Insulet position peaked at $1.94M in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.